Perspectives and Opportunities for Precompetitive Public–Private Partnerships in the Biomedical Sector

Abstract

Biotechnology Law ReportVol. 32, No. 3 Original ArticlesPerspectives and Opportunities for Precompetitive Public–Private Partnerships in the Biomedical SectorH. Stevens, G. Van Overwalle, B. Van Looy, and I. HuysH. StevensSearch for more papers by this author, G. Van OverwalleSearch for more papers by this author, B. Van LooySearch for more papers by this author, and I. HuysSearch for more papers by this authorPublished Online:13 Jun 2013https://doi.org/10.1089/blr.2013.9929AboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited ByOpen innovation: A paradigm shift in pharma R&D?Drug Discovery Today, Vol. 27, No. 9Public-Private Partnerships: Compound and Data Sharing in Drug Discovery and Development13 February 2021 | SLAS DISCOVERY: Advancing the Science of Drug Discovery, Vol. 26, No. 5Driving innovation in biotechnology with Private-Public Partnerships: A Singapore perspectiveBiotechnology Notes, Vol. 2OPEN INNOVATION IN PUBLIC RESEARCH INSTITUTES — SUCCESS AND INFLUENCING FACTORS23 August 2019 | International Journal of Innovation Management, Vol. 23, No. 07A conical-helix model of technology transfer and public-private partnerships for technological development in Brazilian public healthTechnology in Society, Vol. 53Innovative Approaches to Increase Access to Medicines in Developing Countries7 December 2017 | Frontiers in Medicine, Vol. 4Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact6 June 2017 | Pharmaceutical Research, Vol. 34, No. 10Adaptation through Collaboration: Developing Novel Platforms to Advance the Delivery of Advanced Therapies to Patients29 May 2017 | Frontiers in Medicine, Vol. 4Product development programs for neglected tropical diseases: A crucial role for expert meetings23 February 2017 | PLOS Neglected Tropical Diseases, Vol. 11, No. 2Managing innovation in the bioeconomy: An open innovation perspectiveBiomass and Bioenergy, Vol. 90Intellectual property policies in early-phase research in public–private partnerships6 May 2016 | Nature Biotechnology, Vol. 34, No. 5Knowledge flows, the influence of national R&D structure and the moderating role of public–private cooperation14 December 2014 | The Journal of Technology Transfer, Vol. 41, No. 1Innovative Medicines Initiative (IMI) Case Study Analysis Reveals the True Added Value of Early-Phase Public-Private Partnerships (PPPs) Hilde Stevens, Geertrui Van Overwalle, Bart Van Looy, and Isabelle Huys17 August 2015 | Biotechnology Law Report, Vol. 34, No. 4Patent-free pact pushes the boundaries of precompetitive research5 June 2014 | Nature Medicine, Vol. 20, No. 6Taking Bacteriophage Therapy Seriously: A Moral ArgumentBioMed Research International, Vol. 2014 Volume 32Issue 3Jun 2013 InformationCopyright 2013, Mary Ann Liebert, Inc.To cite this article:H. Stevens, G. Van Overwalle, B. Van Looy, and I. Huys.Perspectives and Opportunities for Precompetitive Public–Private Partnerships in the Biomedical Sector.Biotechnology Law Report.Jun 2013.131-139.http://doi.org/10.1089/blr.2013.9929Published in Volume: 32 Issue 3: June 13, 2013Online Ahead of Print:May 6, 2013PDF download